Progenics Pharmaceuticals
| Public | |
| Traded as | NASDAQ: PGNX |
| Industry | Healthcare |
| Headquarters | 777 Old Saw Mill River Road, Tarrytown, New York, United States |
Key people |
Peter J. Crowley (Chairman) Mark Robert Baker (Chief Executive Officer) |
| Products | Biopharmaceuticals |
| Website | progenics.com |
Progenics Pharmaceuticals is an American biopharmaceutical corporation. It is listed on the NASDAQ.[1][2] It creates and sells medicine for HIV, Hepatitis C, and cancer.[1]
References
- 1 2 "Progenics Pharmaceuticals Inc". Bloomberg Business. Retrieved November 6, 2015.
- ↑ "Progenics Pharmaceuticals Inc.". MarketWatch. Retrieved November 6, 2015.
This article is issued from Wikipedia - version of the Friday, November 06, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.